Get in touch
555-555-5555
mymail@mailservice.com
Improving Critical Care, One Molecule At A Time
Sibboran - Landiolol Hydrochloloride
Trimedic Therapeutics has introduced Sibboran, an ultra-short acting beta-blocker.
Indication
The short-term reduction of ventricular rate in patients with supraventricular tachycardia including atrial fibrillation and atrial flutter in perioperative, postoperative, or other acute circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
TRIMEDIC THERAPEUTICS
116-B Viceroy Road, Unit 1, Concord, ON., L4K 2M2
Mon – Fri: 9am – 4:30pm EST